Xencor
Xencor is a California-based biopharmaceutical company that discovers and develops monoclonal antibody and cytokine therapy for the treatment of asthma diseases.
Business Model:
Revenue: $297M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Xencor Information
Geographic Data
Address: 111 West Lemon Avenue
City: Monrovia
State: CA
Zip: 91016
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$133M
Social
Metrics
1,739,884Website Global Rank
13,580Website Monthly Traffic
Twitter Followers
Description
Xencor is a California-based biopharmaceutical company that discovers and develops monoclonal antibody and cytokine therapy for the treatment of asthma diseases.
Contact Phone:
+16263055900
Contact Email:
Xencor went public on 12/3/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/3/2013
IPO Valuation:
$162M
Ticker Symbol:
XNCR
IPO Price:
$5.5/share
Amount Raised:
$70M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2022 | Zenas BioPharma | Series B | 0 |
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
